capecitabine has been researched along with n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beijnen, JH; Copalu, W; Etienne-Grimaldi, MC; Huitema, AD; Milano, G; Schellens, JH; Siegel-Lakhai, WS; Zandvliet, AS | 1 |
Beijnen, JH; DiƩras, V; Girre, V; Huitema, AD; King, A; Milano, G; Richmond, E; Schellens, JH; Siegel-Lakhai, WS; Tibben, MM; Wanders, J; Zandvliet, AS | 1 |
1 trial(s) available for capecitabine and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide
Article | Year |
---|---|
PK/PD model of indisulam and capecitabine: interaction causes excessive myelosuppression.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Drug Administration Schedule; Drug Interactions; Female; Fluorouracil; Humans; Male; Middle Aged; Models, Biological; Neutropenia; Sulfonamides | 2008 |
1 other study(ies) available for capecitabine and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide
Article | Year |
---|---|
A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Capecitabine; Cytochrome P-450 CYP2C9; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Sulfonamides | 2008 |